Halozyme Therapeutics, Inc. Common Stock (HALO)

Typically moves ±6.35% on earnings
EARNINGS ANALYTICS
event_upcoming Est. Next Earnings: 2026-10-12 ESTIMATED
search

Halozyme Therapeutics, Inc. Common Stock (HALO) has reported earnings 20 times since Aug 09, 2021. The stock moves an average of ±6.35% the day after reporting, closing higher 85.0% of the time. Its largest post-earnings gain was +20.08% (Aug 06, 2026) and its largest decline was -9.12% (Feb 17, 2026). The next earnings report is predicted for 2026-10-12 (estimated).

Earnings reactions

How HALO moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

20

Avg Abs. Movement

±6.35%

Positive %

85.0%

Negative %

15.0%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Aug 06, 2026 ☽ POST +20.08% open_in_new
May 11, 2026 ☽ POST +6.78% open_in_new
Feb 17, 2026 ☽ POST -9.12% open_in_new
Nov 03, 2025 ☽ POST +2.72% open_in_new
event

Earnings Count

20

Total earnings in dataset

trending_up

Avg Abs. Movement

±6.35%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 40 →
40
Funds holding
$3333851416
Total value held
Buying
29 added · 10 reduced
Blackrock, Inc.
$1053580752 +12.24%
State Street Corp
$424587547 +30.84%
Invesco Ltd.
$248741825 NEW BUY
Morgan Stanley
$225227160 +5.43%
Bank Of America Corp /De/
$214503722 -5.92%

Frequently asked about HALO earnings

When does Halozyme Therapeutics, Inc. Common Stock report earnings next? expand_more

Halozyme Therapeutics, Inc. Common Stock (HALO)'s next earnings date is estimated for 2026-10-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does HALO stock move after earnings? expand_more

Over 20 reports, HALO has moved an average of ±6.35% the session after earnings, closing higher 85.0% of the time.

What was HALO's biggest post-earnings move? expand_more

HALO's largest post-earnings gain on record was +20.08% on Aug 06, 2026, and its largest decline was -9.12% on Feb 17, 2026.

Where can I find Halozyme Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of Halozyme Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.